Literature DB >> 33363663

EPILEPTIC SEIZURES AS THE FIRST MANIFESTATION OF FAHR'S SYNDROME.

M M Manea1,2, A Sirbu3,4, D Dragos5,6, A M Dobri2, A G Sirbu7, S Tuta1,2.   

Abstract

INTRODUCTION: Hypoparathyroidism is a rare endocrine disorder, leading to complications affecting the kidneys, the eyes, the cerebrum (Fahr's syndrome, epilepsy, parkinsonism, cognitive impairment), and the heart. CASE REPORT: We present the case of a 24-year old male that presented to our clinic for generalized tonic-clonic seizures increasing in frequency for the last year or so. Furthermore, he was diagnosed with subcapsular cataract of both eyes and had intraocular lens implant surgery 12 years ago. CT scan performed at admission showed calcium deposits on the dentate nuclei, basal ganglia, thalamus, cerebellum and bilateral subcortical fronto-parietal white matter compatible with Fahr's disease. The results of the laboratory tests were normal except for hypocalcemia, hyperphosphoremia and low intact parathormone (iPTH). The patient was diagnosed with primary hypoparathyroidism which led to Fahr's syndrome. The patient was prescribed oral medication including calcium carbonate, calcidiol, magnesium orotate and levetiracetam. The follow-up after three months revealed a seizure free status and normalization of magnesium, calcium, and phosphorus levels.
CONCLUSION: Fahr's syndrome can be a cause of epileptic seizures and should be considered in the clinical approach to an epileptic patient, especially in children, teenagers, and young adults. ©by Acta Endocrinologica Foundation.

Entities:  

Keywords:  Fahr’s syndrome; epileptic seizures; primary hypoparathyroidism

Year:  2020        PMID: 33363663      PMCID: PMC7748227          DOI: 10.4183/aeb.2020.370

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  15 in total

1.  Neuropsychological alterations in patients with computed tomography-detected basal ganglia calcification.

Authors:  D López-Villegas; J Kulisevsky; J Deus; C Junqué; J Pujol; E Guardia; J M Grau
Journal:  Arch Neurol       Date:  1996-03

2.  Practice parameter: a guideline for discontinuing antiepileptic drugs in seizure-free patients--summary statement. Report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors: 
Journal:  Neurology       Date:  1996-08       Impact factor: 9.910

Review 3.  Clinical presentation and management of hypoparathyroidism.

Authors:  Gemma Marcucci; Luisella Cianferotti; Maria Luisa Brandi
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-09-28       Impact factor: 4.690

Review 4.  [Mechanism of intracerebral calcification in hypoparathyroidism].

Authors:  Takuo Fujita
Journal:  Clin Calcium       Date:  2004-06

5.  Fahr's Disease or Fahr's Syndrome?

Authors:  Malathi Latha Perugula; Steven Lippmann
Journal:  Innov Clin Neurosci       Date:  2016-08-01

6.  Seizures in patients with idiopathic hypoparathyroidism: effect of antiepileptic drug withdrawal on recurrence of seizures and serum calcium control.

Authors:  Sagar Modi; Manjari Tripathi; Soma Saha; Ravinder Goswami
Journal:  Eur J Endocrinol       Date:  2014-04-10       Impact factor: 6.664

Review 7.  Hypocalcemia-induced seizure: demystifying the calcium paradox.

Authors:  Pengcheng Han; Bradley J Trinidad; Jiong Shi
Journal:  ASN Neuro       Date:  2015-03-24       Impact factor: 4.146

8.  Fahr's syndrome presenting with epileptic seizure: Two case reports.

Authors:  Nedim Ongun; Eylem Degirmenci; Cagdas Erdogan
Journal:  North Clin Istanb       Date:  2016-05-01

Review 9.  Fahr's syndrome: literature review of current evidence.

Authors:  Shafaq Saleem; Hafiz Muhammad Aslam; Maheen Anwar; Shahzad Anwar; Maria Saleem; Anum Saleem; Muhammad Asim Khan Rehmani
Journal:  Orphanet J Rare Dis       Date:  2013-10-08       Impact factor: 4.123

10.  Epileptic seizure, as the first symptom of hypoparathyroidism in children, does not require antiepileptic drugs.

Authors:  Meng-Jia Liu; Jiu-Wei Li; Xiu-Yu Shi; Lin-Yan Hu; Li-Ping Zou
Journal:  Childs Nerv Syst       Date:  2016-12-12       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.